PLSE - Pulse Biosciences, Inc.
IEX Last Trade
18.1
-0.315 -1.740%
Share volume: 1,408
Last Updated: Fri 27 Dec 2024 08:30:00 PM CET
Surgical and Medical Instrument Manufacturing :
-0.06%
PREVIOUS CLOSE
CHG
CHG%
$18.42
-0.32
-1.71%
View ratios
Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
Report Date | 2022-05-11 | 2022-08-10 | 2022-11-10 | 2023-03-31 | 2023-05-11 | 2023-08-10 | 2023-11-13 | |
Assets | ||||||||
Total Assets | 39.534 M | 40.597 M | 87.570 M | 77.877 M | 70.221 M | 74.757 M | 65.945 M | |
Current Assets | 22.163 M | 23.739 M | 71.161 M | 62.147 M | 54.947 M | 59.958 M | 51.623 M | |
Inventories | 7.487 M | 7.871 M | 750.000 K | 0.000 | 0.000 | 0.000 | 0.000 | |
Other Current Assets | 1.979 M | 1.062 M | 1.244 M | 1.008 M | 849.000 K | 1.211 M | 1.237 M | |
Short Term Investments | 1.979 M | 1.062 M | 1.244 M | 1.008 M | 849.000 K | 1.211 M | 1.237 M | |
Total Receivables | 21.000 K | 8.000 K | 5.000 K | 0.000 | 0.000 | 0.000 | 0.000 | |
Current Cash | 12.676 M | 14.798 M | 69.162 M | 61.139 M | 54.098 M | 58.747 M | 50.386 M | |
Total Non-current Assets | 17.371 M | 16.858 M | 16.409 M | 15.730 M | 15.274 M | 14.799 M | 14.322 M | |
Property Plant Equipment | 2.554 M | 2.386 M | 2.286 M | 1.961 M | 1.865 M | 1.755 M | 1.648 M | |
Other Assets | 8.976 M | 8.798 M | 8.615 M | 8.427 M | 8.234 M | 8.035 M | 7.831 M | |
Intangible Assets | 3.050 M | 2.883 M | 2.717 M | 2.551 M | 2.384 M | 2.218 M | 2.052 M | |
Goodwill | 2.791 M | 2.791 M | 2.791 M | 2.791 M | 2.791 M | 2.791 M | 2.791 M | |
Liabilities and shareholders’ equity | ||||||||
Total Liabilities and shareholders’ equity | 39.534 M | 40.597 M | 87.570 M | 77.877 M | 70.221 M | 74.757 M | 65.945 M | |
Total liabilities | 18.738 M | 17.182 M | 81.381 M | 80.125 M | 80.889 M | 14.257 M | 13.800 M | |
Total current liabilities | 8.905 M | 7.564 M | 6.998 M | 5.981 M | 6.991 M | 5.613 M | 5.432 M | |
Accounts Payable | 3.486 M | 1.948 M | 2.022 M | 1.573 M | 2.160 M | 1.794 M | 1.412 M | |
Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Current long term debt | 799.000 K | 827.000 K | 956.000 K | 1.813 M | 1.736 M | 975.000 K | 1.016 M | |
Long term debt | 9.833 M | 9.618 M | 74.383 M | 74.144 M | 73.898 M | 8.644 M | 8.368 M | |
Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Total Shareholder equity | 20.796 M | 23.415 M | 6.189 M | -2.248 M | -10.668 M | 60.500 M | 52.145 M | |
Common stock | 29.745 M | 31.492 M | 37.158 M | 37.345 M | 37.390 M | 44.512 M | 54.923 M | |
Retained earnings | -253.473 M | -267.469 M | -285.508 M | -294.705 M | -304.506 M | -314.416 M | -324.982 M |